Areteia Therapeutics - Contact

Pioneering a New Era In Asthma Control

Our Advanced Candidate: Dexpramipexole

Who We Are

Eosinophilic Asthma

A New Approach

How Did We Get Here?

Phase 3 Development Program

News Releases

Publications

Presentations

Home Pioneering a New Era
In Asthma Control Our Advanced Candidate: Dexpramipexole Who We Are

About Us Eosinophilic Asthma

Our Science A New Approach How Did We Get Here Phase 3 Development Program

News News Releases Publications Presentations

Contact Us

Email

[email protected]

[email protected]

Headquarters

Areteia Therapeutics, Inc.
101 Glen Lennox Dr
Suite 300
Chapel Hill, NC 27517

|

|

Eosinophilic Asthma

|

|

|

Terms of Service

Accessibility Policy

© 2022 Areteia Therapeutics